AmplifAI Secures $33.7M to Enhance Contact Center Performance with AI
AmplifAI has raised $33.7M in Series B funding to unify human and AI agent performance in contact centers, driving better customer experiences.
Dallas, TX – AmplifAI, a leading AI-powered platform for contact center performance, has announced a $33.7 million Series B funding round led by CVS Health Ventures, with participation from LiveOak Ventures and Dallas Venture Partners. The investment will accelerate the company's mission to unify human and AI agent performance, delivering scalable, best-in-class customer experiences.
Transforming Contact Centers with AI
AmplifAI's platform addresses the growing pressure on contact centers to reduce costs while improving customer loyalty, retention, and sales. By adopting an AI-first approach, the platform ensures human agents handle complex, high-value interactions, while AI agents manage routine contacts. This unified approach optimizes workflows and enhances efficiency across all levels of the contact center.
Key Insights from Investors
"AmplifAI’s capabilities bring greater consistency and effectiveness to call center operations by providing leaders with clear insights into behaviors that drive success," said Vijay Patel of CVS Health Ventures. "These insights help organizations identify skill gaps, tailor coaching, and scale best practices, ultimately elevating the customer experience."
How AmplifAI Works
The platform integrates multi-channel data, including customer surveys, voice recordings, chat, and chatbot conversations, with metrics and behavioral data. By applying generative AI, AmplifAI uncovers hidden customer pain points and generates real-time coaching, workflows, and automated actions. This reduces friction, strengthens loyalty, and delivers measurable business outcomes.
Proven Impact
Since its founding in 2018, AmplifAI has partnered with leading brands in retail, healthcare, financial services, and tech, achieving:
- 100%+ increase in sales conversion
- Nearly 10% reduction in cost per contact
- 20%+ improvement in resolution rates
The company was also recognized as a Cool Vendor by Gartner in 2024 and a Leading Pioneer in the Automated QA/QM Prism by CMP Research.
Leadership Vision
"We are reimagining the contact center with human-centric AI—empowering people to be more effective while virtual agents reduce costs, together delivering an optimal customer experience," said Sean Minter, CEO of AmplifAI.
About AmplifAI
AmplifAI transforms raw interaction data into actionable insights, helping enterprises enhance customer experience, agent effectiveness, and operational efficiency. Learn more at https://amplifai.com.
About CVS Health Ventures
CVS Health Ventures is a corporate venture capital fund focused on making healthcare more accessible, affordable, and simpler. For more information, visit cvshealthventures.com.
Contact: Robert Cowlishaw, Email: rcowlishaw@amplifai.com
Source: BusinessWire
Related News
6sense Unveils AI Email Agents Appoints Chris Ball as CEO
6sense launches AI Email Agents for personalized outreach at scale while naming Chris Ball as its new CEO to drive global expansion.
How AI and Data Shape Future Ad Tech for Brands
Brands leverage AI, data, and composable apps to develop next-gen marketing platforms
About the Author
Dr. Emily Wang
AI Product Strategy Expert
Former Google AI Product Manager with 10 years of experience in AI product development and strategy formulation. Led multiple successful AI products from 0 to 1 development process, now provides product strategy consulting for AI startups while writing AI product analysis articles for various tech media outlets.